Patent Assignment
Reel/Frame 056168/0602
Security Interest
Recorded: 2021-05-06
Pages: 82
Assignor
KALA PHARMACEUTICALS, INC.
Executed: 2021-05-04
Assignee
OXFORD FINANCE LLC
115 SOUTH UNION STREET, SUITE 3000, ALEXANDRIA, VIRGINIA, 22314
Covered Properties
(108)
Particles, Compositions, and Methods for Ophthalmic and/or Other Applications
PCT:
PCT/US2017/051873 ↗
Functionalized Poly(Ether-Anhydride) Block Copolymers
Nanocrystals, Compositions, and Methods That Aid Particle Transport in Mucus
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Application:
13/886,602 →
Publication:
US 2013/0316006
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Application:
13/886,658 →
Publication:
US 2013/0316001
Compositions and Methods for Ophthalmic and/or Other Applications
Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Urea Derivatives and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Nanocrystals, Compositions, and Methods That Aid Particle Transport in Mucus
Nanocrystals, Compositions, and Methods That Aid Particle Transport in Mucus
Therapeutic Compounds and Uses Thereof
Meropenem Derivatives and Uses Thereof
Compounds for Treatment of Diseases of Abnormal Angiogenesis or Aberrant Growth Factors and Uses Thereof
Urea Derivatives and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Nanocrystals, Compositions, and Methods That Aid Particle Transport in Mucus
Nanocrystals, Compositions, and Methods That Aid Particle Transport in Mucus
Urea Derivatives and Uses Thereof
Crystalline Forms of a Therapeutic Compound and Uses Thereof
1-Amino-triazolo(1,5-A)pyridine-substituted Urea Derivative and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Nanocrystals, Compositions, and Methods That Aid Particle Transport in Mucus
Meropenem Derivatives and Uses Thereof
Compositions and Methods Comprising Medium Chain Triglycerides for Treatment of Epilepsy
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Urea Derivatives and Uses Thereof
Urea Derivatives and Uses Thereof
Compositions and Methods for Ophthalmic and/or Other Applications
Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Novel Compounds and Uses Thereof
Nanocrystals, Compositions, and Methods That Aid Particle Transport in Mucus
Compositions and Methods for Ophthalmic and/or Other Applications
Compositions and Methods for Ophthalmic and/or Other Applications
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Application:
15/992,494 →
Publication:
US 2018/0271782
Novel Compounds and Uses Thereof
Urea Derivatives and Uses Thereof
Urea Derivatives and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
1-Amino-triazolo(1,5-A)pyridine-substituted Urea Derivative and Uses Thereof
Compositions and Methods for Ophthalmic and/or Other Applications
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Application:
16/331,472 →
Publication:
US 2019/0216824
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Application:
16/331,474 →
Publication:
US 2019/0216726
Therapeutic Compounds and Uses Thereof
Urea Derivatives and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Novel Compounds and Uses Thereof
Particles, Compositions, and Methods for Ophthalmic and/or Other Applications
Application:
16/502,635 →
Publication:
US 2020/0016084
Meropenem Derivatives and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Biochemical binding of RET9 and VEGFR2 inhibitors
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Compositions and Methods Utilizing Poly(Vinyl Alcohol) and/or Other Polymers That Aid Particle Transport in Mucus
Compositions and Methods for Ophthalmic and/or Other Applications
Compositions and Methods for Ophthalmic and/or Other Applications
Urea Derivatives and Uses Thereof
Therapeutic Compounds and Uses Thereof
Nanocrystals, Compositions, and Methods That Aid Particle Transport in Mucus
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Application:
16/945,398 →
Publication:
US 2021/0052489
Compositions and Methods for Ophthalmic and/or Other Applications
Compositions and Methods for Ophthalmic and/or Other Applications
1-Amino-triazolo(1,5-A)pyridine-substituted Urea Derivative and Uses Thereof
Application:
17/112,542 →
Publication:
US 2021/0087192
Novel Compounds and Uses Thereof
Application:
17/165,791 →
Publication:
US 2021/0380588
Compositions and Methods for Ophthalmic and/or Other Applications
Therapeutic Compounds and Uses Thereof
Application:
17/180,388 →
Publication:
US 2021/0393641
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Compositions and Methods for Ophthalmic and/or Other Applications
Compositions and Methods for Ophthalmic and/or Other Applications
Functionalized poly (ether-anhydride) block copolymers
Application:
60/635,280 →
Nanocrystals, Compositions, and Methods That Aid Particle Transport in Mucus
Application:
61/642,227 →
Compositions and Methods Utilizing Poly(Vinyl Alcohol) and/or Other Polymers That Aid Particle Transport in Mucus
Application:
61/642,261 →
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Application:
61/642,313 →
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Application:
61/738,949 →
Therapeutic Compounds and Uses Thereof
Application:
61/765,487 →
Therapeutic Compounds and Uses Thereof
Application:
61/767,087 →
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Application:
61/784,701 →
Meropenem Derivatives and Uses Thereof
Application:
61/789,335 →
Novel compounds and uses thereof
Application:
61/829,117 →
Urea Derivatives and Uses Thereof
Application:
61/833,853 →
Novel Compounds and Uses Thereof
Application:
61/898,719 →
Urea Derivatives and Uses Thereof
Application:
61/898,720 →
Therapeutic Compounds and Uses Thereof
Application:
61/898,741 →
Therapeutic Compounds and Uses Thereof
Application:
61/898,778 →
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application:
62/039,177 →
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application:
62/039,192 →
Crystalline Forms of A Therapeutic Compound and Uses Thereof
Application:
62/084,682 →
Urea Derivative and Uses Thereof
Application:
62/090,045 →
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application:
62/385,148 →
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application:
62/385,154 →
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application:
62/385,155 →
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Application:
62/395,980 →
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Application:
62/395,984 →
Biochemical Binding of RET9 and VEGFR2 Inhibitors
Application:
62/575,280 →
Particles, Compositions, and Methods for Ophthalmic and/or Other Applications
Application:
62/694,805 →
Particles, Compositions, and Methods for Ophthalmic and/or Other Applications
Application:
62/694,819 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Nov 30, 2010
From: KALA PHARMACEUTICALS, INC.
To: LUX VENTURES II, L.P.; LUX VENTURES II SIDECAR, L.P.; POLARIS VENTURE PARTNERS V, L.P.; POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.
Reel/Frame 025414/0032 →
Security Agreement
Jul 19, 2011
From: KALA PHARMACEUTICALS, INC.
To: LIGHTHOUSE CAPITAL PARTNERS VI, L.P.
Reel/Frame 026611/0985 →
Release of Security Interest
Mar 13, 2012
From: LUX VENTURES II, L.P.; LUX VENTURES II SIDECAR, L.P.; THIRD ROCK VENTURES, L.P.; POLARIS VENTURE PARTNERS V, L.P.
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 027850/0171 →
Release of Security Interest
Mar 13, 2012
From: LIGHTHOUSE CAPTIAL PARTNERS VI, L.P.
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 027850/0340 →
Corrective Assignment to Correct the Name of the Assignor Previously Recorded on Reel 027850 Frame 0340. Assignor(S) Hereby Confirms the Correct Name of the Assignor Is Lighthouse Capital Partners Vi, L.P.
Mar 15, 2012
From: LIGHTHOUSE CAPITAL PARTNERS VI, L.P.
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 027870/0777 →
Nunc Pro Tunc Assignment
Sep 24, 2012
From: HANES, JUSTIN; FU, JIE
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 029013/0866 →
Nunc Pro Tunc Assignment
Sep 24, 2012
From: HANES, JUSTIN; FU, JIE
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 029013/0893 →
Nunc Pro Tunc Assignment
Sep 24, 2012
From: THE JOHNS HOPKINS UNIVERSITY
To: HANES, JUSTIN; FU, JIE
Reel/Frame 029013/0882 →
Assignment of Assignor's Interest
Jul 8, 2013
From: ENSIGN, LAURA M.; LAI, SAMUEL K.; YU, TAO; HANES, JUSTIN
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 030751/0828 →
Assignment of Assignor's Interest
Jul 8, 2013
From: POPOV, ALEXEY; ENLOW, ELIZABETH M.; CHEN, HONGMING
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 030752/0016 →
Assignment of Assignor's Interest
Jul 8, 2013
From: POPOV, ALEXEY; ENLOW, ELIZABETH M.; BOURASSA, JAMES; GARDNER, COLIN R.
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 030751/0583 →
Assignment of Assignor's Interest
May 6, 2014
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032829/0862 →
Assignment of Assignor's Interest
May 6, 2014
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032829/0986 →
Assignment of Assignor's Interest
May 6, 2014
From: ASKEW, BEN C.
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 032829/0966 →
Assignment of Assignor's Interest
May 9, 2014
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032861/0976 →
Assignment of Assignor's Interest
May 9, 2014
From: ASKEW, BEN
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 032861/0868 →
Assignment of Assignor's Interest
May 9, 2014
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032861/0803 →
Assignment of Assignor's Interest
May 13, 2014
From: POPOV, ALEXEY; ENLOW, ELIZABETH M.; CHEN, HONGMING; BOURASSA, JAMES
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032878/0838 →
Assignment of Assignor's Interest
Aug 8, 2014
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO; NGUYEN, MINH NGOC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 033493/0135 →
Confirmatory License
Sep 29, 2014
From: KALA PHARMACEUTICALS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033845/0429 →
Confirmatory License
Sep 29, 2014
From: KALA PHARMACEUTICALS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033845/0492 →
Assignment of Assignor's Interest
Nov 6, 2014
From: ENLOW, ELIZABETH; NGUYEN, MINH NGOC; ONG, WINSTON Z
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 034113/0739 →
Assignment of Assignor's Interest
Sep 25, 2015
From: ASKEW, BEN C.
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 036661/0974 →
Assignment of Assignor's Interest
Sep 25, 2015
From: ONG, WINSTON Z.; NOWAK, PAWEL W.; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 036661/0915 →
Assignment of Assignor's Interest
Sep 25, 2015
From: BREAKTROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 036662/0081 →